Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719030 · ClinicalTrials.gov registry record · NA
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00719030 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 25 participants.
The verdict
NCT00719030, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of pomegranate polyphenol pills (POM-X) and a placebo (sugar pill) on prostatic oxidative stress. The placebo is a pill that looks like the POM-X pill but does not have an active ingredient.
Interventions
- DIETARY_SUPPLEMENT Pomegranate pill
- DIETARY_SUPPLEMENT Pomegranate pill placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00719030
The ClinicalTrials.gov registry entry for NCT00719030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pomegranate pill is the first listed.
NCT00719030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00719030 about?
NCT00719030 is a clinical study titled "A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy". The purpose of this study is to compare the effects of pomegranate polyphenol pills (POM-X) and a placebo (sugar pill) on prostatic oxidative stress. The placebo is a pill that looks like the POM-X pill but does not have an active ingredient.
What is the current status of trial NCT00719030?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2009-02. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00719030?
The interventions under investigation include: Pomegranate pill (DIETARY_SUPPLEMENT), Pomegranate pill placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00719030?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.